Cargando…

Cutaneous CD56(+) T-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma

Detalles Bibliográficos
Autores principales: Zheng, Yixuan James, Lee, Albert, Pincus, Laura, Ho, Wilson, Vujic, Marin, Ortiz-Urda, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991899/
https://www.ncbi.nlm.nih.gov/pubmed/29892669
http://dx.doi.org/10.1016/j.jdcr.2018.01.016
_version_ 1783329930590814208
author Zheng, Yixuan James
Lee, Albert
Pincus, Laura
Ho, Wilson
Vujic, Marin
Ortiz-Urda, Susana
author_facet Zheng, Yixuan James
Lee, Albert
Pincus, Laura
Ho, Wilson
Vujic, Marin
Ortiz-Urda, Susana
author_sort Zheng, Yixuan James
collection PubMed
description
format Online
Article
Text
id pubmed-5991899
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-59918992018-06-11 Cutaneous CD56(+) T-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma Zheng, Yixuan James Lee, Albert Pincus, Laura Ho, Wilson Vujic, Marin Ortiz-Urda, Susana JAAD Case Rep Case Report Elsevier 2018-06-06 /pmc/articles/PMC5991899/ /pubmed/29892669 http://dx.doi.org/10.1016/j.jdcr.2018.01.016 Text en © 2018 Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Zheng, Yixuan James
Lee, Albert
Pincus, Laura
Ho, Wilson
Vujic, Marin
Ortiz-Urda, Susana
Cutaneous CD56(+) T-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma
title Cutaneous CD56(+) T-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma
title_full Cutaneous CD56(+) T-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma
title_fullStr Cutaneous CD56(+) T-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma
title_full_unstemmed Cutaneous CD56(+) T-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma
title_short Cutaneous CD56(+) T-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma
title_sort cutaneous cd56(+) t-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991899/
https://www.ncbi.nlm.nih.gov/pubmed/29892669
http://dx.doi.org/10.1016/j.jdcr.2018.01.016
work_keys_str_mv AT zhengyixuanjames cutaneouscd56tcelllymphomadevelopingduringpembrolizumabtreatmentformetastaticmelanoma
AT leealbert cutaneouscd56tcelllymphomadevelopingduringpembrolizumabtreatmentformetastaticmelanoma
AT pincuslaura cutaneouscd56tcelllymphomadevelopingduringpembrolizumabtreatmentformetastaticmelanoma
AT howilson cutaneouscd56tcelllymphomadevelopingduringpembrolizumabtreatmentformetastaticmelanoma
AT vujicmarin cutaneouscd56tcelllymphomadevelopingduringpembrolizumabtreatmentformetastaticmelanoma
AT ortizurdasusana cutaneouscd56tcelllymphomadevelopingduringpembrolizumabtreatmentformetastaticmelanoma